This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Laurocapram
- DrugBank Accession Number
- DB17308
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved
- Structure
Structure for Laurocapram (DB17308)
- Weight
- Average: 281.484
Monoisotopic: 281.271864751 - Chemical Formula
- C18H35NO
- Synonyms
- 1-dodecylazacycloheptan-2-one
- 1-dodecylhexahydro-2h-azepin-2-one
- 1-n-dodecylazacycloheptan-2-one
- 2h-azepin-2-one, 1-dodecylhexahydro-
- Azone
- N-dodecyl-.epsilon.-caprolactam
- External IDs
- N-0252
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Fatazen Sweat Enhance Hot Laurocapram (0.8 g/100g) + Capsaicin (0.008 g/100g) + Vanillyl butyl ether (0.8 g/100g) Cream Topical Guangzhou Guocui Biological Technology Co., Ltd 2023-12-20 Not applicable US 
- Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Fatazen Sweat Enhance Hot Laurocapram (0.8 g/100g) + Capsaicin (0.008 g/100g) + Vanillyl butyl ether (0.8 g/100g) Cream Topical Guangzhou Guocui Biological Technology Co., Ltd 2023-12-20 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 1F3X9DRV9X
- CAS number
- 59227-89-3
- InChI Key
- AXTGDCSMTYGJND-UHFFFAOYSA-N
- InChI
- InChI=1S/C18H35NO/c1-2-3-4-5-6-7-8-9-10-13-16-19-17-14-11-12-15-18(19)20/h2-17H2,1H3
- IUPAC Name
- 1-dodecylazepan-2-one
- SMILES
- CCCCCCCCCCCCN1CCCCCC1=O
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0253992
- ChemSpider
- 39176
- 1603852
- ChEMBL
- CHEMBL76591
- ZINC
- ZINC000008214596
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Cream Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.000526 mg/mL ALOGPS logP 5.32 ALOGPS logP 5.41 Chemaxon logS -5.7 ALOGPS pKa (Strongest Basic) -0.89 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 20.31 Å2 Chemaxon Rotatable Bond Count 11 Chemaxon Refractivity 87.04 m3·mol-1 Chemaxon Polarizability 37.26 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at December 05, 2022 17:15 / Updated at December 06, 2022 13:40